Free Trial

Journey Medical (DERM) Institutional Ownership

Journey Medical logo
$5.37 +0.17 (+3.27%)
(As of 11/22/2024 ET)

Institutional Ownership Changes (13F Filings) for Journey Medical (NASDAQ:DERM)

Current
Institutional Ownership
Percentage
7.25%
Number of
Institutional Buyers
(last 12 months)
10
Total
Institutional Inflows
(last 12 months)
$4.46M
Number of
Institutional Sellers
(last 12 months)
6
Total
Institutional Outflows
(last 12 months)
$1.13M
Get DERM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Journey Medical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

DERM Institutional Buying and Selling by Quarter

Journey Medical Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/16/2024 Geode Capital Management LLC108,435$613K0.0%+13.5%0.523%
11/15/2024 Kovitz Investment Group Partners LLC11,605$66K0.0%N/A0.056%
11/14/2024 Walleye Capital LLC23,098$131K0.0%-63.7%0.111%
11/12/2024 Nwam LLC10,430$59K0.0%N/A0.050%
11/1/2024 Atria Investments Inc44,397$251K0.0%-19.8%0.214%
10/30/2024 Rosalind Advisors Inc.105,917$598K0.4%-7.2%0.529%
10/11/2024 ORG Wealth Partners LLC19,519$110K0.0%N/A0.094%
8/22/2024PVG Asset Management Corp158,540$894K3.5%N/A0.792%
8/9/2024 Renaissance Technologies LLC264,025$1.49M0.0%-2.4%1.319%
8/8/2024TMD Wealth Management LLC11,605$65K0.0%N/A0.058%
8/6/2024 Acadian Asset Management LLC94,404$531K0.0%-57.6%0.472%
7/26/2024 Cambridge Investment Research Advisors Inc.294,950$1.66M0.0%N/A1.474%
7/12/2024 Rosalind Advisors Inc.114,132$644K0.5%N/A0.570%
5/14/2024 Heron Bay Capital Management33,669$124K0.0%N/A0.169%
5/10/2024 Acadian Asset Management LLC222,663$817K0.0%+687.5%1.117%
5/10/2024 Perkins Capital Management Inc.22,000$81K0.1%-31.3%0.110%
5/10/2024 Nwam LLC11,820$41K0.0%N/A0.059%
(Data available from 1/1/2016 forward)

DERM Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of DERM shares?

During the previous two years, 14 institutional investors and hedge funds held shares of Journey Medical. The most heavily invested institutionals were Cambridge Investment Research Advisors Inc. ($1.66M), Renaissance Technologies LLC ($1.49M), PVG Asset Management Corp ($894K), Geode Capital Management LLC ($613K), Rosalind Advisors Inc. ($598K), Acadian Asset Management LLC ($531K), and Atria Investments Inc ($251K).Learn more on DERM's institutional investors.

What percentage of Journey Medical stock is owned by institutional investors?

7.25% of Journey Medical stock is owned by institutional investors. Learn more on DERM's institutional investor holdings.

Which institutional investors have been buying Journey Medical stock?

Of the 10 institutional investors that purchased Journey Medical stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Cambridge Investment Research Advisors Inc. ($294.95K), Acadian Asset Management LLC ($194.39K), PVG Asset Management Corp ($158.54K), Rosalind Advisors Inc. ($114.13K), Heron Bay Capital Management ($33.67K), Nwam LLC ($22.25K), and ORG Wealth Partners LLC ($19.52K).

How much institutional buying is happening at Journey Medical?

Institutional investors have bought a total of 873,541 shares in the last 24 months. This purchase volume represents approximately $4.46M in transactions.

Which Journey Medical major shareholders have been selling company stock?

The following institutional investors have sold Journey Medical stock in the last 24 months: Acadian Asset Management LLC ($128.26K), Walleye Capital LLC ($40.48K), Atria Investments Inc ($10.94K), Perkins Capital Management Inc. ($10K), Rosalind Advisors Inc. ($8.22K), and Renaissance Technologies LLC ($6.58K).

How much institutional selling is happening at Journey Medical?

Institutional investors have sold a total of 204,470 shares in the last 24 months. This volume of shares sold represents approximately $1.13M in transactions.



This page (NASDAQ:DERM) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners